London Daily

Focus on the big picture.
Sunday, Jun 08, 2025

Covid: Ivermectin to be studied as possible treatment in UK

Covid: Ivermectin to be studied as possible treatment in UK

University of Oxford scientists are trialling giving Ivermectin to over-50s with Covid symptoms to see if it can keep them out of hospital.

The Principle study will compare those given the drug to patients receiving the usual, standard NHS care.

The drug has become controversial after being promoted for use across Latin America and in South Africa, despite being so far unproven.

Previous studies of Ivermectin have generally been small or low quality.

Some South Africans have been demanding the authorities allow Ivermectin to be used

Most commonly used to treat parasitic infections such as river blindness, spread by flies, Ivermectin has also been shown to kill viruses in petri dishes in the lab - although, at much higher doses than would usually be prescribed.

Though there have been some early "promising" results from small and observational studies, Principle joint chief investigator Prof Richard Hobbs said it would be "premature" to recommend Ivermectin for Covid.

Observational studies look at people already taking the drug, rather than giving it to a group representative of the population.

So they fail to account for differences in the types of people who might choose that treatment.

'Gold standard'


A study of this type previously suggested antibiotic Azithromycin might be helping Covid patients - but the Principle study later showed the drug was ineffective.

Trials such as Principle are seen as the "gold standard" because they can be much more sure of measuring the effects of the drug and not that of other factors.

Despite the lack of good evidence so far, Ivermectin has been taken up by doctors and by individuals self-medicating in countries including Brazil, Bolivia, Peru and South Africa.

In the US, provider SingleCare said 817 prescriptions had been filled for Ivermectin, which can also be used to treat skin conditions such as rosacea, in January and February 2021, compared with 92 in the same period last year.

And the Oxford team said the reasons they had selected Ivermectin for trial included because it was:

*  "readily available globally"

*  familiar in many countries

*  known to be relatively safe

Of the six other drugs in the Principle study of Covid treatments to be taken at home, only one - inhaled steroid budesonide - has so far proved effective.

Although, sister project the Recovery trial, of treatments for hospital patients, also discovered another steroid, dexamethasone, could treat Covid, which has been credited with saving more than 20,000 lives in the UK.

Over-50s with an underlying health condition or experiencing breathlessness can sign up to the Principle study if they have had Covid symptoms for up to 14 days.

Newsletter

Related Articles

0:00
0:00
Close
Trump Administration Issues New Travel Ban Targeting 12 Countries
Man Group Mandates Full-Time Office Return for Quantitative Analysts
JPMorgan Warns Analysts Against Accepting Future-Dated Job Offers
Builder.ai Faces Legal Scrutiny Amid Financial Misreporting Allegations
Japan Grapples with Rice Shortage Amid Soaring Prices
Goldman Sachs Reduces Risk Exposure Amid Market Volatility
HSBC Chairman Mark Tucker to Return to AIA as Non-Executive Chair
Israel Confirms Arming Gaza Clan to Counter Hamas Influence
Judge Blocks Trump's Ban on International Students at Harvard
Trump Proposes Travel Ban on 'Uncontrolled' Countries
Chad Suspends Visa Issuance to U.S. Citizens in Retaliation
Xi Jinping and Donald Trump Hold First Call Since Trade War Began
Global News Roundup: From Ukraine's strategic military strikes and Russia's demands and Tensions Escalate in Ukraine, to serious legal issues faced by Britons in Bali and Trump's media criticism, the latest developments highlight a turbulent landscape
Majority of French Voters View Macron's Presidency as a Failure
Hungary Partners with China to Boost Electric Vehicle Production
‘Vibe Coding’ Emerges as the New DIY Trend
AI Pioneer Yoshua Bengio Warns Models Can Deceive Users
Big Four Firms Rush to Create AI Auditing Systems
Musk’s xAI Pursues $113 Billion Valuation in New Share Sale
Walmart Increases Revenue Despite Shrinking Workforce
Hims & Hers Plans UK and EU Launch of Replica Obesity Drugs
Toyota to Acquire Supplier in $33 Billion Buyout
U.S. Reduces Military Presence in Syria
Trump Demands Iran End All Uranium Enrichment in Nuclear Talks
China Accuses US of Violating Trade Truce
Panama Port Owner Balances US-China Pressures
France Implements Nationwide Outdoor Smoking Ban to Protect Children
German Chancellor Merz Keeps Putin Guessing on Missile Strategy
Mandelson Criticizes UK's 'Fetish' for Abandoning EU Regulations
British Fishing Boat Owner Fined €30,000 by French Authorities
Dutch government falls as far-right leader Wilders quits coalition
Harvard Urges US to Unfreeze Funds for Public Health Research
Businessman Mauled by Lion at Luxury Namibian Lodge
Researchers Consider New Destinations Beyond the U.S.
53-Year-Old Doctor Claims Biological Age of 23
Trump Struggles to Secure Trade Deals With China and Europe
Russia to Return 6,000 Corpses Under Ukraine Prisoner Swap Deal
Microsoft Lays Off Hundreds More Amid Restructuring
Harvey Weinstein’s Publicist Embraces Notoriety
Macron and Meloni Seek Unity Despite Tensions
Trump Administration Accused of Obstructing Deportation Cases
Newark Mayor Sues Over Arrest at Immigration Facility
Center-Left Candidate Projected to Win South Korean Presidency
Trump’s Tariffs Predicted to Stall Global Economic Growth
South Korea’s President-Elect Expected to Take Softer Line on Trump and North Korea
Trump’s China Strategy Remains a Geopolitical Puzzle
Ukraine Executes Long-Range Drone Strikes on Russian Airbases
Conservative Karol Nawrocki wins Poland’s presidential election
Study Identifies Potential Radicalization Risk Among Over One Million Muslims in Germany
Good news: Annalena Baerbock Elected President of the UN General Assembly
×